Design, Synthesis, and Biological Evaluation of Ferulic Acid-Piperazine Derivatives Targeting Pathological Hallmarks of Alzheimer’s Disease-Reference-Cited by-同舟云学术

Design, Synthesis, and Biological Evaluation of Ferulic Acid-Piperazine Derivatives Targeting Pathological Hallmarks of Alzheimer’s Disease

Published:2024-07-30 Issue:15 Volume:15 Page:2756-2778
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Singh Gourav¹,Kumar Sunil¹,Panda Samir Ranjan²,Kumar Prabhat³,Rai Sanskriti⁴,Verma Himanshu¹,Singh Yash Pal¹^ORCID,Kumar Saroj⁴,Srikrishna Saripella³^ORCID,Naidu V.G.M.²,Modi Gyan¹^ORCID

Affiliation:

1. Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Rm # 123, Varanasi 221005, India

2. Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, Assam 781032, India

3. Department of Biophysics, All India Institute of Medical Sciences, New Delhi 110029, India

4. Department of Biochemistry, Institute of Sciences, Banaras Hindu University, Varanasi 201005, India

Funder

Indian Council of Medical Research

Science and Engineering Research Board

Indian Institute of Technology (BHU) Varanasi

Ministry of Education, India

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.4c00130

Reference85 articles.

1. Alzheimer Disease

2. Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer’s Agents: Synthesis and Biological Evaluation

3. Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease:

4. Design and development of benzyl piperazine linked 5-phenyl-1,2,4-triazole-3-thione conjugates as potential agents to combat Alzheimer’s disease

5. Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection